Cargando…
Clustering based on adherence data
Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068077/ https://www.ncbi.nlm.nih.gov/pubmed/21385451 http://dx.doi.org/10.1186/1742-5573-8-3 |
_version_ | 1782201177811714048 |
---|---|
author | Kiwuwa-Muyingo, Sylvia Oja, Hannu Walker, Sarah A Ilmonen, Pauliina Levin, Jonathan Todd, Jim |
author_facet | Kiwuwa-Muyingo, Sylvia Oja, Hannu Walker, Sarah A Ilmonen, Pauliina Levin, Jonathan Todd, Jim |
author_sort | Kiwuwa-Muyingo, Sylvia |
collection | PubMed |
description | Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe. |
format | Text |
id | pubmed-3068077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30680772011-03-31 Clustering based on adherence data Kiwuwa-Muyingo, Sylvia Oja, Hannu Walker, Sarah A Ilmonen, Pauliina Levin, Jonathan Todd, Jim Epidemiol Perspect Innov Methodology Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe. BioMed Central 2011-03-08 /pmc/articles/PMC3068077/ /pubmed/21385451 http://dx.doi.org/10.1186/1742-5573-8-3 Text en Copyright ©2011 Kiwuwa-Muyingo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Kiwuwa-Muyingo, Sylvia Oja, Hannu Walker, Sarah A Ilmonen, Pauliina Levin, Jonathan Todd, Jim Clustering based on adherence data |
title | Clustering based on adherence data |
title_full | Clustering based on adherence data |
title_fullStr | Clustering based on adherence data |
title_full_unstemmed | Clustering based on adherence data |
title_short | Clustering based on adherence data |
title_sort | clustering based on adherence data |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068077/ https://www.ncbi.nlm.nih.gov/pubmed/21385451 http://dx.doi.org/10.1186/1742-5573-8-3 |
work_keys_str_mv | AT kiwuwamuyingosylvia clusteringbasedonadherencedata AT ojahannu clusteringbasedonadherencedata AT walkersaraha clusteringbasedonadherencedata AT ilmonenpauliina clusteringbasedonadherencedata AT levinjonathan clusteringbasedonadherencedata AT toddjim clusteringbasedonadherencedata |